Sunday share tips: Purplebricks, Associated British Foods, Angle
12th Jun 2016 13:28
(ShareCast News) - Purplebricks Group shares were a 'buy' in the Sunday Times' Inside the City column. Investing in this online estate agency might be a wild ride, with the shares trading for more than 40 times earnings, but some notable names are on the register since its IPO at the end of last yea
Read moreAngle closer to using cassette tech for prostate cancer detection
21st Mar 2016 14:04
(ShareCast News) - There was praise for the progress made by Angle on Monday, in its quest to see one of its existing products used as a diagnostic tool for prostate cancer. The AIM-traded company was the subject of a report by equity advisory firm Edison, which said that while the final data was ye
Read moreAngle posts positive prostate cancer treatment tests update
11th Jun 2015 11:39
Medical diagnostic company Angle said the investigation into the clinical use of its Parsortix system in prostate cancer treatments was encouraging. Researchers from Barts Cancer Institute, which is carrying out the tests, were able to successfully harvest circulating tumor cells from all the 52 ass
Read moreAngle to collaborate with USC Norris on breast cancer treatment
19th Sep 2014 08:28
AIM-listed medtech group Angle has signed a collaboration agreement with the University of Southern California (USC) Norris Comprehensive Cancer Center to investigate the clinical use of the Parsortix system for breast cancer. The collaboration follows four months of evaluation by USC Norris of Angl
Read moreAngle wins EU authorisation for Parsortix
17th Dec 2013 11:53
Medical diagnostic device maker Angle has won European approval for a system used in the diagnosis and treatment of cancer patients. Angle said regulators had authorized its Parsortix cell separation system for use as an in-vitro diagnostic device in the EU. The system uses blood analysis to diagn
Read moreANGLE sells Geomerics business to ARM Holdings
13th Dec 2013 11:41
Specialist medtech company ANGLE has raised 6.2m pounds after realising its investment in graphics technology developer Geomerics, which it sold to ARM Holdings. The group said the additional financial resources will be used within its Parsortix non-invasive cancer diagnostics business, enabling i
Read moreAngle shares jump on cell harvesting update
13th May 2013 14:34
Shares in Angle, a specialist medtech company, leapt 20 per cent on Monday after the group said it has extended the operational capability of its Parsortix non-invasive cancer diagnostic product by automating its cell harvesting function. Harvesting is where captured tumour cells are recovered from
Read moreAngle initiates launch of cancer diagnostic product for market research
28th Feb 2013 13:36
Angle, an AIM-listed specialist medtech company, has initiated the launch of its Parsortix non-invasive cancer diagnostic product for the research market. The product is based on taking a blood test, and the system either counts circulating tumour cells (CTCs) in the blood or captures and recovers
Read moreAngle raises funds with placing
31st Jan 2013 13:13
Angle, a specialist medtech company, has placed 4.53m new ordinary shares at 50p each, representing a discount of 17.4 per cent on the mid-price of 60.50p per share at close of business on Wednesday. Net of costs, the placing raised £2.2m, which will be used to strengthen the company's financial p
Read moreAngle jumps again after pay out
15th Jan 2013 08:47
Medical technology firm Angle saw its shares jump for a second day in a row after it received cash due from the sale of its portfolio company Acoylte Biomedica. The 2007 sale led to a legal case over an earn-out provision, which saw former Acolyte shareholder, Porton Capital, take the buyer, 3M, to
Read moreAngle gains on breakthrough in cancer diagnostic technology
14th Jan 2013 09:46
Angle advanced more than 90 per cent Monday after the medtech company announced a major breakthrough in its cancer diagnostic product Parsotix. The AIM listed company said it had edged further in the development of Parsortix, a non-invasive technology which captures and counts rare circulating tu
Read moreSharp drop in Angle shares following business update
10th Dec 2012 15:01
AIM-listed medtech company Angle revealed that Origio, a partner involved in the development of a technology patented as EmbryoSure, has decided to cease EmbryoSure studies in a business update on Monday. EmbryoSure is a technology being developed to assess the viability of embryos for transfer in
Read moreSmall caps round-up: Cyan, Aer Lingus, Mobile Tornado ...
7th Jun 2012 13:59
Cyan Holdings, the wireless solutions company, has revealed that three more Cyan partners have received requests from the Tamil Nadu Electricity Board (TNEB) Automatic Meter Reading tender to proceed with installation and commissioning of 500 unit pilots within the next 25 days. The news follows Cya
Read moreSmall caps round-up: Westminster Group, Angle, Asterand
30th Apr 2012 08:47
Defence technology firm Westminster Group said its investment in a West African airport was looking promising and that an initial aggregate $150m revenue forecast could be achieved by the contract's eight year break point rather than the full contract term of 15 years. "Should that be the case, the
Read moreSmall caps round up: Intandem, Digital Learning, Hornby ...
23rd Apr 2012 14:31
Intandem Films, the London and Los Angeles based international film group, will co-produce 10 Things I Hate About Life, and sell the film internationally. The company will also distribute the film in the UK. The script has been written and the film will be directed by Gil Junger, the director of the
Read more